A mutation in the thyroid hormone receptor alpha gene

Elena Bochukova1, Nadia Schoenmakers, Maura Agostini

  • 1University of Cambridge Metabolic Research Laboratories and National Institute for Health Research Cambridge Biomedical Research Centre, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.

Insights

Thyroid hormone resistance can occur due to mutations in thyroid hormone receptor alpha (THRA). A child

Area of Science:

  • Endocrinology
  • Genetics
  • Molecular Biology

Background:

  • Thyroid hormones regulate growth and development via alpha (TRα) and beta (TRβ) receptors.
  • Defects in thyroid hormone signaling can lead to hypothyroidism with varying clinical severity.

Observation:

  • A child presented with severe hypothyroidism symptoms but only borderline thyroid hormone levels.
  • Whole-exome sequencing revealed a de novo heterozygous nonsense mutation in the THRA gene.

Findings:

  • The identified THRA mutation produced a mutant protein with dominant-negative inhibitory effects on the wild-type receptor.
  • This indicates a novel form of human thyroid hormone resistance mediated by defective TRα function.

Implications:

  • Substantiates the distinct roles of TRα and TRβ receptor subtypes in mediating thyroid hormone action.
  • Highlights the importance of considering genetic defects in thyroid hormone receptors for diagnosing unexplained hypothyroidism.
  • Provides insights into the molecular mechanisms of thyroid hormone resistance.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
68
Mutations01:39

Mutations

Overview
96.4K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.5K
Mutations01:39

Mutations

No description available
13.7K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
26.3K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.9K